Total IgE at 6 months predicts remittance or persistence of atopic dermatitis at 14 months

Norio Kawamoto1, Toshiyuki Fukao, Hideo Kaneko

  • 1Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.

Insights

Total IgE at 6 months is a key predictor for persistent infantile atopic dermatitis (AD). Higher levels indicate a higher likelihood of AD continuing past 14 months of age.

Area of Science:

  • Immunology
  • Pediatrics
  • Dermatology

Background:

  • Infantile atopic dermatitis (AD) outcomes vary, with some infants achieving remission while others experience persistent disease.
  • Predictive markers for infantile AD prognosis remain unclear, necessitating further research.

Purpose of the Study:

  • To identify predictive markers for the outcome of infantile atopic dermatitis (AD).
  • To differentiate between transient and persistent AD in infants using laboratory data.

Main Methods:

  • A birth cohort study followed 314 infants from birth to 14 months.
  • Cord blood was collected, and physical examinations and blood tests were performed at 6 and 14 months for a subset of participants (n=144).
  • Laboratory data, including lymphocyte percentages and IgE levels, were compared between infants with transient AD (n=16) and persistent AD (n=18) at 6 months.

Main Results:

  • Infants with persistent AD showed significantly higher percentages of CD8+ T cells in cord blood and higher total IgE levels at 6 months compared to the transient group.
  • Receiver operating characteristic (ROC) analysis indicated predictive value for these markers (AUCs 0.792 and 0.722).
  • Persistent AD was associated with elevated total IgE, T-helper (Th) 2 cell percentages, and IL-4 production at 14 months, confirming Th2 polarization.

Conclusions:

  • Total IgE levels at 6 months of age are a valuable and practical predictive marker for the long-term outcome of infantile atopic dermatitis.
  • Th2 immune response polarization is evident in infants with persistent AD.
  • Early identification of infants at risk for persistent AD can potentially guide timely interventions.